Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Goldenwell Biotech's revenue for the twelve months ending Jun 30, 2026 was $55. For fiscal 2025 it was $55, down 60.4% from the year before. The highest annual figure on record is $47.80K in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55 | -60.4% |
| FY2024 | Dec 31, 2024 | $139 | -92.4% |
| FY2023 | Dec 31, 2023 | $1.84K | -96.2% |
| FY2022 | Dec 31, 2022 | $47.80K | +199.4% |
| FY2021 | Dec 31, 2021 | $15.97K | – |
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $55 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $139 | -49.6% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $260 | – |
| Q3 FY2023 | Sep 30, 2023 | $382 | -99.1% |
| Q2 FY2023 | Jun 30, 2023 | $276 | -92.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.42K | +258.2% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $43.69K | +259.1% |
| Q2 FY2022 | Jun 30, 2022 | $3.71K | +235.7% |
| Q1 FY2022 | Mar 31, 2022 | $397 | – |
| Q4 FY2021 | Dec 31, 2021 | $4.91K | – |
| Q3 FY2021 | Sep 30, 2021 | $12.17K | – |
| Q2 FY2021 | Jun 30, 2021 | $1.11K | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
See a number that looks wrong?